We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+7.89%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$314B
AUM Growth
+$19.1B
Cap. Flow
+$92.3M
Cap. Flow %
0.03%
Top 10 Hldgs %
20.84%
Holding
3,440
New
118
Increased
1,247
Reduced
1,874
Closed
82

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.37B
2
DD icon
DuPont de Nemours
DD
+$556M
3
QCOM icon
Qualcomm
QCOM
+$405M
4
MRK icon
Merck
MRK
+$333M
5
TSM icon
TSMC
TSM
+$315M

Sector Composition

Rank Sector Weight
1 Technology 23.31%
2 Consumer Discretionary 12.98%
3 Financials 12.81%
4 Healthcare 12.54%
5 Communication Services 9.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DNLI icon
1476
Denali Therapeutics
DNLI
$3.97B
$15.9M 0.01%
277,621
-14,241
-5% -$953K
DHC
1477
Diversified Healthcare Trust
DHC
$2.14B
$15.8M 0.01%
3,307,923
-462,636
-12% -$2.13M
ENVA icon
1478
Enova International
ENVA
$6.29B
$15.8M 0.01%
445,416
-20,045
-4% -$600K
MOG.A icon
1479
Moog Inc Class A
MOG.A
$12.8B
$15.8M 0.01%
190,031
-5,582
-3% -$446K
BGC icon
1480
BGC Group
BGC
$4.89B
$15.8M 0.01%
3,265,073
+173,657
+6% +$739K
MMP
1481
DELISTED
Magellan Midstream Partners, L.P.
MMP
$15.7M 0.01%
362,994
+354,013
+3,942% +$15.5M
CORE
1482
DELISTED
Core Mark Holding Co., Inc.
CORE
$15.7M 0.01%
406,379
+5,120
+1% +$177K
GNMK
1483
DELISTED
GenMark Diagnostics, Inc
GNMK
$15.7M 0.01%
656,928
-459,795
-41% -$8.55M
GATX icon
1484
GATX Corp
GATX
$6.27B
$15.7M 0.01%
169,069
+276
+0.2% +$25.7K
WLY icon
1485
John Wiley & Sons Class A
WLY
$2.66B
$15.7M 0.01%
288,829
+55,296
+24% +$2.81M
AMSF icon
1486
AMERISAFE
AMSF
$540M
$15.6M 0.01%
244,435
-154,571
-39% -$9.28M
IRWD icon
1487
Ironwood Pharmaceuticals
IRWD
$714M
$15.6M 0.01%
1,396,804
+527,067
+61% +$5.57M
BRC icon
1488
Brady Corp
BRC
$4.57B
$15.6M 0.01%
291,846
+72,287
+33% +$3.78M
PZZA icon
1489
Papa John's
PZZA
$806M
$15.6M 0.01%
175,798
+23,673
+16% +$2.24M
AMRX icon
1490
Amneal Pharmaceuticals
AMRX
$5.79B
$15.5M ﹤0.01%
2,309,907
+1,734,350
+301% +$9.61M
SPWR
1491
DELISTED
SunPower Corporation Common Stock
SPWR
$15.5M ﹤0.01%
464,496
+21,433
+5% +$803K
ALLK
1492
DELISTED
Allakos
ALLK
$15.5M ﹤0.01%
135,304
+32,110
+31% +$4.06M
RDUS
1493
DELISTED
Radius Recycling
RDUS
$15.5M ﹤0.01%
371,566
+46,160
+14% +$1.68M
VRNT
1494
DELISTED
Verint Systems
VRNT
$15.5M ﹤0.01%
341,253
-954,460
-74% -$42.7M
MRTN icon
1495
Marten Transport
MRTN
$1.22B
$15.5M ﹤0.01%
913,841
+250,787
+38% +$4.24M
IBOC icon
1496
International Bancshares
IBOC
$4.57B
$15.5M ﹤0.01%
333,855
+7,656
+2% +$336K
MDC
1497
DELISTED
M.D.C. Holdings, Inc.
MDC
$15.5M ﹤0.01%
260,540
+8,208
+3% +$430K
VC icon
1498
Visteon
VC
$2.78B
$15.5M ﹤0.01%
126,893
-81,096
-39% -$10.6M
UNF icon
1499
Unifirst Corp
UNF
$5.25B
$15.4M ﹤0.01%
68,943
-523
-0.8% -$120K
EVTC icon
1500
Evertec
EVTC
$1.78B
$15.3M ﹤0.01%
412,403
+52
+0% +$1.96K

Similar funds

Nuveen's Q1 2021 Portfolio in Review

As of Q1 2021, Nuveen held 3,440 positions worth $314B, up 6.5% from $295B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Nuveen's Q1 2021 filing shows 118 new, 1,247 increased, 1,874 reduced and 82 closed positions. Its largest new stake was Coupang: 6,313,287 shares worth $312M. The largest sale was Apple, an estimated $1.37B.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Nuveen's largest Q1 2021 buy was Coupang: 6,313,287 shares worth $312M.
  • Nuveen added most to Intel in Q1 2021, an estimated $905M increase.
  • Nuveen's biggest Q1 2021 reduction was Apple, cutting an estimated $1.37B.
  • Nuveen fully exited PARSLEY ENERGY INC in Q1 2021, selling an estimated $122M.
  • Nuveen's ten largest holdings make up 21% of its $314B portfolio in Q1 2021.
  • Nuveen opened 118 new positions and closed 82 in Q1 2021.
  • Nuveen's portfolio value rose 6.5% quarter-over-quarter to $314B.

Based on Nuveen's 13F filing for Q1 2021, filed 17 May 2021.